Cargando…

Expression of TFRC helps to improve the antineoplastic effect of Ara-C on AML cells through a targeted delivery carrier

BACKGROUND: Currently, high doses of cytarabine arabinoside (Ara-C)-based combined chemotherapy are commonly used in acute myeloid leukemia (AML) therapy, but severe adverse effects and poor suppression effects in leukemia cells limit the clinical therapeutic efficiency of Ara-C-based chemotherapy d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Xinzhou, Jiao, Zhouguang, Zhang, Junying, Li, Feng, Li, Yuhua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10088114/ https://www.ncbi.nlm.nih.gov/pubmed/37041636 http://dx.doi.org/10.1186/s12951-023-01881-8

Ejemplares similares

Stabilization of SAMHD1 by NONO is crucial for Ara-C resistance in AML
por: Zhang, Feifei, et al.
Publicado: (2022)

Circumvention of ara-C resistance by aphidicolin in blast cells from patients with AML
por: Sargent, J M, et al.
Publicado: (2001)

Antineoplastics Encapsulated in Nanostructured Lipid Carriers
por: Rodrigues da Silva, Gustavo Henrique, et al.
Publicado: (2021)

MYCN mediates TFRC-dependent ferroptosis and reveals vulnerabilities in neuroblastoma
por: Lu, Yuxiong, et al.
Publicado: (2021)

Cellular Intrinsic Mechanism Affecting the Outcome of AML Treated with Ara-C in a Syngeneic Mouse Model
por: Zhao, Wenjun, et al.
Publicado: (2014)

The Addition of Arsenic Trioxide to Low Dose Ara-C in Older Patients with AML Does Not Improve Outcome
por: Burnett, Alan K, et al.
Publicado: (2011)

Inhibitors of Chemoresistance Pathways in Combination with Ara-C to Overcome Multidrug Resistance in AML. A Mini Review
por: Fajardo-Orduña, Guadalupe Rosario, et al.
Publicado: (2021)

Role of TFRC as a Novel Prognostic Biomarker and in Immunotherapy for Pancreatic Carcinoma
por: Yang, Cheng, et al.
Publicado: (2022)

Circular RNA cTFRC acts as the sponge of MicroRNA-107 to promote bladder carcinoma progression
por: Su, Hongwei, et al.
Publicado: (2019)

YTHDF1-enhanced iron metabolism depends on TFRC m(6)A methylation
por: Ye, Jing, et al.
Publicado: (2020)

Clinical and Immunological Characterization of Combined Immunodeficiency Due to TFRC Mutation in Eight Patients
por: Aljohani, Amal H., et al.
Publicado: (2020)

NCBP2 and TFRC are novel prognostic biomarkers in oral squamous cell carcinoma
por: Arora, Rahul, et al.
Publicado: (2023)

Ara solar
por: Anguiano Valadez, Adolfo, 1917-
Publicado: (1974)

Knockdown of ANXA10 induces ferroptosis by inhibiting autophagy-mediated TFRC degradation in colorectal cancer
por: Wang, Xinyuan, et al.
Publicado: (2023)

Association of genetic polymorphisms in genes involved in Ara-C and dNTP metabolism pathway with chemosensitivity and prognosis of adult acute myeloid leukemia (AML)
por: Zhu, Ke-Wei, et al.
Publicado: (2018)

TFRC upregulation promotes ferroptosis in CVB3 infection via nucleus recruitment of Sp1
por: Yi, Lu, et al.
Publicado: (2022)

Using genome-wide CRISPR library screening with library resistant DCK to find new sources of Ara-C drug resistance in AML
por: Kurata, Morito, et al.
Publicado: (2016)

P1362: FEASIBILITY OF HAEMATOPOIETIC STEM CELL MOBILIZATION AFTER CONSOLIDATION WITH GEMTUZUMAB OZOGAMICIN AND INTERMEDIATE-DOSES ARA-C AND DAUNORUBICIN IN AML
por: Perrone, S., et al.
Publicado: (2022)

TFRC and ACTB as the best reference genes to quantify Urokinase Plasminogen Activator in breast cancer
por: Majidzadeh-A, Keivan, et al.
Publicado: (2011)

A missense mutation in TFRC, encoding transferrin receptor 1, causes combined immunodeficiency
por: Jabara, Haifa H., et al.
Publicado: (2015)

Liposomally trapped AraCTP to overcome AraC resistance in a murine lymphoma in vitro.
por: Richardson, V. J., et al.
Publicado: (1982)

DNA tape measurements of AraC
por: Rodgers, Michael E., et al.
Publicado: (2008)

The Takata-Ara Test
por: Chaudhuri, R. N., et al.
Publicado: (1943)

An Improved Enzyme-Linked Immunosorbent Assay (ELISA) Based Protocol Using Seeds for Detection of Five Major Peanut Allergens Ara h 1, Ara h 2, Ara h 3, Ara h 6, and Ara h 8
por: Pandey, Arun K., et al.
Publicado: (2019)

Sorting nexin 3 exacerbates doxorubicin-induced cardiomyopathy via regulation of TFRC-dependent ferroptosis
por: Yu, Wenjing, et al.
Publicado: (2023)

Publisher Correction: Knockdown of ANXA10 induces ferroptosis by inhibiting autophagy-mediated TFRC degradation in colorectal cancer
por: Wang, Xinyuan, et al.
Publicado: (2023)

Mesenchymal Stromal Cells for Antineoplastic Drug Loading and Delivery
por: Petrella, Francesco, et al.
Publicado: (2017)

Ara h 2 is the dominant peanut allergen despite similarities with Ara h 6
por: Hemmings, Oliver, et al.
Publicado: (2020)

Antineoplastic Agents Targeting Sphingolipid Pathways
por: Kroll, Alexander, et al.
Publicado: (2020)

El ara : instructivo para el aprendiz masón.
Publicado: (1974)

O-GlcNAcylation enhances sensitivity to RSL3-induced ferroptosis via the YAP/TFRC pathway in liver cancer
por: Zhu, Guoqing, et al.
Publicado: (2021)

Eine neue Ära beginnt!
por: Klimek, Ludger, et al.
Publicado: (2020)

IgE cross-reactivity between the major peanut allergen Ara h 2 and the non-homologous allergens Ara h 1 and Ara h 3
por: Bublin, M, et al.
Publicado: (2013)

Randomized evaluation of quizartinib and low-dose ara-C vs low-dose ara-C in older acute myeloid leukemia patients
por: Dennis, Mike, et al.
Publicado: (2021)

TFRC–RNA interactions show the regulation of gene expression and alternative splicing associated with IgAN in human renal tubule mesangial cells
por: Li, Jian-Si, et al.
Publicado: (2023)

Involvement of ORAI1/SOCE in Human AML Cell Lines and Primary Cells According to ABCB1 Activity, LSC Compartment and Potential Resistance to Ara-C Exposure
por: Lewuillon, Clara, et al.
Publicado: (2022)

Ara h 6 complements Ara h 2 as an important marker for IgE reactivity to peanut
por: Hindley, J, et al.
Publicado: (2013)

Tumor targeting using liposomal antineoplastic drugs
por: Huwyler, Jörg, et al.
Publicado: (2008)

Evidence for tankyrases as antineoplastic targets in lung cancer
por: Busch, Alexander M, et al.
Publicado: (2013)

Targeting glioma cells by antineoplastic activity of reversine
por: Hirakata, Camila, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3qoqqihvfeis02aaif90g741n3